Objective:

To quantify the incidence and risk of receiving psychiatric and psychological care among patients with atopic dermatitis, hidradenitis suppurativa, and psoriasis, and to explore potential sex differences as a secondary objective.

Key Findings:

• Patients with atopic dermatitis, hidradenitis suppurativa, and psoriasis have significantly higher rates of psychiatric evaluation, psychotherapy, and psychiatric pharmacotherapy compared to matched controls.
• Psychotherapy is particularly utilized by patients with atopic dermatitis, while pharmacological treatment is most pronounced in those with hidradenitis suppurativa.
• Women generally show higher rates of psychiatric and psychological care in atopic dermatitis, with specific patterns observed in hidradenitis suppurativa and psoriasis.

Interpretation:

The findings highlight the necessity for integrated, multidisciplinary management strategies that address both dermatologic and mental health needs in patients with chronic inflammatory skin diseases, emphasizing the importance of mental health care in treatment plans.

Limitations:

• The study relies on deidentified electronic health records, which may limit the depth of clinical insights and understanding of patient experiences.
• Potential confounding factors may still exist despite propensity score matching.

Conclusion:

The study underscores the necessity for healthcare systems to incorporate mental health care into the treatment plans for patients with chronic inflammatory skin diseases.